These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4155636)

  • 21. Biotransformation and pharmacokinetics of tetrazepam in man.
    Baumgärtner MG; Cautreels W; Langenbahn H
    Arzneimittelforschung; 1984; 34(6):724-9. PubMed ID: 6148954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differences in pharmacokinetics of bromazepam following oral and rectal administration].
    Fukushima K; Sato T
    Masui; 1982 May; 31(5):512-7. PubMed ID: 6127419
    [No Abstract]   [Full Text] [Related]  

  • 23. [Simulation of kinetics of phenazepam and its metabolite 3-hydroxyphenazepam in cat blood].
    Zherdev VP; Ekonomov AL; Brestkina LM; Janku I; Havlik I
    Biull Eksp Biol Med; 1982 Oct; 94(10):54-6. PubMed ID: 7171799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics, plasma protein binding and time response relationships of 2-amino-5-phenyl-2-oxazolin-4-one (pemoline) in the horse.
    Igwe OJ; Blake JW
    Drug Metab Dispos; 1983; 11(2):120-5. PubMed ID: 6133715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man.
    Schiantarelli P; Acerbi D; Bovis G
    Arzneimittelforschung; 1981; 31(1):92-7. PubMed ID: 6971114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
    Breimer DD; Jochemsen R; von Albert HH
    Arzneimittelforschung; 1980; 30(5a):875-81. PubMed ID: 6106488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of alprazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):45-7. PubMed ID: 6135693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Pharmacokinetics of diazepam in man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R48. PubMed ID: 4276585
    [No Abstract]   [Full Text] [Related]  

  • 30. Chlorpropamide bioavailability and pharmacokinetics.
    Huupponen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):331-3. PubMed ID: 7263111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical choice of a benzodiazepine].
    Villeneuve A
    Encephale; 1983; 9(4 Suppl 2):253B-259B. PubMed ID: 6144521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic studies after oral and parenteral application of dipotassium chlorazepate (author's transl)].
    Staak M; Moosmayer A; Besserer K; Speidel K; Kleinschmidt A
    Arzneimittelforschung; 1982; 32(3):272-5. PubMed ID: 6123331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man.
    Küpfer A; Desmond PV; Schenker S; Branch RA
    J Pharmacol Exp Ther; 1982 Jun; 221(3):590-7. PubMed ID: 7086673
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of intravenous camazepam in dogs.
    Legheand J; Cuisinaud G; Bernard N; Riotte M; Sassard J
    Arzneimittelforschung; 1982; 32(7):752-6. PubMed ID: 6127087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlating pharmacokinetics and pharmacodynamics of benzodiazepines: problems and assumptions.
    Greenblatt DJ; Friedman HL; Shader RI
    Psychopharmacol Ser; 1987; 3():62-71. PubMed ID: 2881293
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative pharmacokinetics of benzodiazepines in dog and man.
    Boxenbaum H
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):411-26. PubMed ID: 6130139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The determination of some 1,4-benzodiazepines and their metabolites in body fluids. A review.
    Clifford JM; Smyth WF
    Analyst; 1974 May; 99(1178):241-72. PubMed ID: 4155921
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetic differentiation of benzodiazepines].
    Vollmer KO
    Fortschr Med; 1981 Jun; 99(21):829-34. PubMed ID: 6114028
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical pharmacology of benzodiazepine tranquilizers].
    Janicki P; Rewerski W
    Pol Tyg Lek; 1981 Aug; 36(34):1313-6. PubMed ID: 6121319
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.
    Greenblatt DJ; Shader RI; Franke K; MacLaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E
    J Pharm Sci; 1979 Jan; 68(1):57-63. PubMed ID: 31453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.